Sort
130,381 grants matching “hiv”
Role of proviral loci in HIV latency
$833,533James Ivan Mullins · University Of Washington · R01 · FY2019 · AI
MAPs for Peds: Development of a Microarray Patch for Delivery of Long-Acting Antiretrovirals for Treatment of Pediatric HIV Infection
$833,526Darin Zehrung · Path · R61 · FY2020 · AI
Therapeutics Targeting Macrophages/Microglia to Eradicate CNS HIV-1 Reservoirs
$833,525Raymond F. Schinazi · Emory University · R01 · FY2016 · MH
Identification of the Initial Targets of Transmission
$833,492Thomas Hope · Northwestern University At Chicago · R37 · FY2017 · AI
Donor-specific anti-HIV/SIV immunity mediated by APOBEC3 enzymes
$833,457Diako Ebrahimi · Texas Biomedical Research Institute · R56 · FY2023 · AI
Core 1: Expression and Molecular Biology (EMB) Core
$833,454Priscilla K Cooper · University Of Calif-Lawrenc Berkeley Lab · P01 · FY2016 · CA
Strategies for inducing bnAbs against QNES by infection with SHIVs
$833,435Shiu-Lok Hu · Univ Of Med/Dent Of Nj-Nj Medical School · P01 · FY2011 · AI
In vivo transformation of chimeric antigen receptor B cells for a functional cure of HIV
$833,420Michael R. Farzan · Boston Children'S Hospital · R01 · FY2025 · AI
Host specific responses in SIV-induced hematosuppression
$833,393Emory University · R01 · FY2004 · HL
Exploratory human trials of rectal microbicides
$833,379Anne-Marie Corner · University Of California Los Angeles · U19 · FY2008 · AI
The Cooperative Re-Engagement Controlled Trial (CoRECT
$833,334Alfred Demaria · Massachusetts State Dept Of Pub Health · U01 · FY2016 · PS
The Cooperative Re-Engagement Controlled Trial (CoRECT)
$833,333Heidi Jenkins · Connecticut State Dept Of Public Health · U01 · FY2016 · PS
Philadelphia Cooperative Agreement Re-engagement Controlled Trial
$833,333Kathleen A Brady · Philadelphia Departmentof Public Health · U01 · FY2016 · PS
Arterial Inflammation and Coronary Microvascular Dysfunction among Women with HIV: Missing Pieces to the MI Risk Puzzle
$833,297Markella V. Zanni · Massachusetts General Hospital · R01 · FY2022 · HL
Arterial Inflammation and Coronary Microvascular Dysfunction among Women with HIV: Missing Pieces to the MI Risk Puzzle
$833,296Markella V. Zanni · Massachusetts General Hospital · R01 · FY2020 · HL
Arterial Inflammation and Coronary Microvascular Dysfunction among Women with HIV: Missing Pieces to the MI Risk Puzzle
$833,296Markella V. Zanni · Massachusetts General Hospital · R01 · FY2021 · HL
Molecular and Clinical Studies of Insulin Resistance
$833,192Rebecca Brown · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2025 · DK
Development of a Sustained Release Injectable Formulation for Long-Term Delivery of ELQs
$833,189Michael Kevin Riscoe · Oregon Health & Science University · R01 · FY2019 · AI
Structural study of the HIV1 gp41 coat protein
$833,178Ad Bax · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2015 · DK
Chemoprophylaxis and HIV-Host Interactions
$833,172Robert M. Grant · J. David Gladstone Institutes · R01 · FY2010 · AI
Blocking type I interferon signaling to reverse T cell exhaustion and control HIV-1 reservoirs
$833,168Lishan Su · University Of Maryland Baltimore · R01 · FY2021 · AI
EPITOPE BASED DNA VACCINES FOR AIDS THERAPY
$833,081Idm Pharma, Inc. · P01 · FY2000 · AI
Development of Small-Molecule HIV Entry Inhibitors
$833,040Progenics Pharmaceuticals, Inc. · R44 · FY2005 · GM
Resubmission: Multilevel Strategies & Tailored HIV Prevention & Care for Young Couples who use Alcohol & Other Drugs Across Cape Town
$833,027Felicia Amira Browne · Research Triangle Institute · R01 · FY2024 · DA
On-site, high-fidelity target sequencing and absolute quantitation for HIV-1 surveillance
$833,025Sanggu Kim · Ohio State University · R01 · FY2021 · HG